Howard Bailey Securities’s AbbVie ABBV Stock Holding History

Howard Bailey Securities’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$354K	Sell	1,407 -30	-2%	-$6.45K	0.13%	73
2026 Q1	$313K	Sell	1,437 -355	-20%	-$78.7K	0.13%	98
2025 Q4	$409K	Buy	1,792 +85	+5%	+$19.4K	0.16%	83
2025 Q3	$395K	Sell	1,707 -1,017	-37%	-$207K	0.11%	90
2025 Q2	$506K	Buy	2,724 +813	+43%	+$151K	0.16%	72
2025 Q1	$400K	Sell	1,911 -91	-5%	-$17.7K	0.13%	93
2024 Q4	$356K	Sell	2,002 -1,196	-37%	-$220K	0.13%	106
2024 Q3	$632K	Buy	+3,198	New	+$597K	0.24%	61

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Howard Bailey Securities's ABBV Position: Q2 2026 in Review

Howard Bailey Securities reduced its AbbVie (ABBV) stake by 2.1% in Q2 2026, selling an estimated $6.45K and leaving 1,407 shares worth $354K. The position accounts for 0.13% of the portfolio, ranked #73.

Howard Bailey Securities first reported a position in ABBV in Q3 2024 and has held it in 8 quarters since. The position peaked at $632K in Q3 2024. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Howard Bailey Securities held 1,407 shares of AbbVie worth $354K as of Q2 2026.
Howard Bailey Securities sold 30 AbbVie shares in Q2 2026, an estimated $6.45K.
AbbVie made up 0.13% of Howard Bailey Securities's portfolio in Q2 2026, its #73 holding.
Howard Bailey Securities first reported a position in AbbVie in Q3 2024 and has held it in 8 quarters since.
Howard Bailey Securities's AbbVie position peaked at $632K in Q3 2024.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Howard Bailey Securities's 13F filing for Q2 2026, filed 10 Aug 2026.